Cpharm wants to build a cannabis processing plant in Afghanistan
Yesterday, officials from the Home Office’s Department of Drug Enforcement met with a representative of the company (Cpharm).
The company wants to build a cannabis processing plant in Afghanistan, which will create all cannabis products.
“The company wants to build a cannabis treatment plant in Afghanistan that will create all the cannabis products,” Khosty said in a tweet.
“The company is set to invest $ 430 million in this sector. This project will officially start in the coming days.”
Cpharm, a small company based in Maitland, NSW, has since been inundated with requests for comment and was forced on Thursday to clarify that it had nothing to do with the Taliban or the apparent deal.
‘No one from here has met with anyone. It has nothing to do with us, ”Cpharm CEO Josie Gabites told SBS News.
“We have nothing to do with the Taliban or with cannabis. And we have no idea where it comes from.
“There is no connection between us and the Taliban or cannabis.”
The company said it was not a manufacturer or supplier of any products but provided medical advice to the pharmaceutical industry in Australia.
“We have no hash. We have no product, we do not produce anything,” Ms Gabites said.
“We provide advice to pharmaceutical companies. We have no products, we do not manufacture, we do not distribute. ”
Australia has a Taliban sanctions regime that imposes restrictions on the supply of assets to “designated persons or entities”.
SBS News has contacted Mr Khosty for clarification.